XML 18 R8.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Apr. 02, 2022
Apr. 03, 2021
Jan. 01, 2022
Operating activities:      
Net income (loss) $ 118,702 $ (263,262)  
Adjustments to reconcile net income to net cash from operating activities:      
Depreciation 18,931 24,142  
Amortization of acquisition intangibles 4,847 6,179  
Other amortization 2,508 3,020  
Impairment of intangible assets and goodwill 0 163,047  
(Gain) loss on sale of business and classification of assets held for sale (6,715) 226,352  
Amortization of debt issuance costs 1,887 4,580  
Other 6,940 (5,835)  
Changes in assets and liabilities:      
Accounts receivable (6,090) (63,955)  
Inventories (247,567) (122,781)  
Other assets (489) 9,606  
Accounts payable (310) 109,197  
Accrued pension and postretirement benefits 24 (38,757)  
Accrued liabilities and other (123,857) (34,587)  
Net cash from operating activities (231,189) 16,946  
Investing activities:      
Capital expenditures (19,337) (17,804)  
Proceeds from sales of assets 19 2,406  
Other (10,272) 1,794  
Net cash from investing activities (29,590) (13,604)  
Financing activities:      
Repayments on Term Loan Facilities (6,250) (300,000)  
Borrowings on Accounts Receivable Securitization Facility 290,000 0  
Repayments on Accounts Receivable Securitization Facility (154,500) 0  
Borrowings on Revolving Loan Facilities 129,000 0  
Repayments on Revolving Loan Facilities (109,000) 0  
Borrowings on notes payable 21,454 21,106  
Repayments on notes payable (21,713) (20,276)  
Share repurchases (25,018) 0  
Cash dividends paid (52,297) (52,351)  
Other (4,109) (2,902)  
Net cash from financing activities 67,567 (354,423)  
Effect of changes in foreign exchange rates on cash 1,793 (17,662)  
Change in cash, cash equivalents and restricted cash (191,419) (368,743)  
Cash, cash equivalents and restricted cash at beginning of year 560,629 910,603 $ 910,603
Cash, cash equivalents and restricted cash at end of period 369,210 541,860 560,629
Less restricted cash at end of period 0 1,153  
Cash and cash equivalents at end of period 369,210 540,707  
Balances included in the Condensed Consolidated Balance Sheets:      
Cash and cash equivalents 369,210 530,403 536,277
Cash and cash equivalents at end of period 369,210 540,707  
Supplemental Cash Flow Information:      
Capital expenditures included in accounts payable at end of period 27,960   24,164
Right-of-use assets obtained in exchange for lease obligations 16,035 4,755  
Discontinued Operations, Held-for-sale | European Innerwear Business      
Adjustments to reconcile net income to net cash from operating activities:      
(Gain) loss on sale of business and classification of assets held for sale (187) 226,352  
Cash and cash equivalents included in current assets held for sale $ 0 $ 10,304 $ 24,352